Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer

Prostate Cancer and Prostatic Diseases, Published online: 24 February 2020; doi:10.1038/s41391-020-0214-6Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer

Source: Prostate Cancer and Prostatic Diseases - February 23, 2020 Category: Urology & Nephrology Authors: Sounak Gupta Chad Vanderbilt Wassim Abida Samson W. Fine Satish K. Tickoo Hikmat A. Al-Ahmadie Ying-Bei Chen Sahussapont J. Sirintrapun Kalyani Chadalavada Gouri J. Nanjangud Ann Bialik Michael J. Morris Howard I. Scher Marc Ladanyi Victor E. Reuter Anura Source Type: research